211 related articles for article (PubMed ID: 30808881)
21. Evidence of digenic inheritance in autoinflammation-associated genes.
Neocleous V; Byrou S; Toumba M; Costi C; Shammas C; Kyriakou C; Christophidou-Anastasiadou V; Tanteles GA; Hadjipanayis A; Phylactou LA
J Genet; 2016 Dec; 95(4):761-766. PubMed ID: 27994174
[TBL] [Abstract][Full Text] [Related]
22. Association of NOD1, NOD2, PYDC1 and PYDC2 genes with Behcet's disease susceptibility and clinical manifestations.
Kocaaga A; Cakmak Genc G; Karakas Celık S; Koca R; Dursun A
Ophthalmic Genet; 2021 Dec; 42(6):691-697. PubMed ID: 34294014
[No Abstract] [Full Text] [Related]
23. Low prevalence of NOD2 SNPs in Behçet's disease suggests protective association in Caucasians.
Kappen JH; Wallace GR; Stolk L; Rivadeneira F; Uitterlinden AG; van Daele PL; Laman JD; Kuijpers RW; Baarsma GS; Stanford MR; Fortune F; Madanat W; van Hagen PM; van Laar JA
Rheumatology (Oxford); 2009 Nov; 48(11):1375-7. PubMed ID: 19748964
[TBL] [Abstract][Full Text] [Related]
24. The absence of disease-specific polymorphisms within the HLA-B51 gene that is the susceptible locus for Behçet's disease.
Sano K; Yabuki K; Imagawa Y; Shiina T; Mizuki N; Ohno S; Kulski JK; Inoko H
Tissue Antigens; 2001 Aug; 58(2):77-82. PubMed ID: 11696219
[TBL] [Abstract][Full Text] [Related]
25. Monogenic mimics of Behçet's disease in the young.
Papadopoulou C; Omoyinmi E; Standing A; Pain CE; Booth C; D'Arco F; Gilmour K; Buckland M; Eleftheriou D; Brogan PA
Rheumatology (Oxford); 2019 Jul; 58(7):1227-1238. PubMed ID: 30715505
[TBL] [Abstract][Full Text] [Related]
26. Association of MICA polymorphism with HLA-B51 and disease severity in Korean patients with Behcet's disease.
Park SH; Park KS; Seo YI; Min DJ; Kim WU; Kim TG; Cho CS; Mok JW; Park KS; Kim HY
J Korean Med Sci; 2002 Jun; 17(3):366-70. PubMed ID: 12068141
[TBL] [Abstract][Full Text] [Related]
27. Association of HLA-B51 subtypes and Behçet's disease in Spain.
González-Escribano MF; Rodríguez MR; Walter K; Sanchez-Roman J; García-Lozano JR; Núñez-Roldán A
Tissue Antigens; 1998 Jul; 52(1):78-80. PubMed ID: 9714478
[TBL] [Abstract][Full Text] [Related]
28. HLA and tumour necrosis factor (TNF) polymorphisms in ocular Behçet's disease.
Verity DH; Wallace GR; Vaughan RW; Kondeatis E; Madanat W; Zureikat H; Fayyad F; Marr JE; Kanawati CA; Stanford MR
Tissue Antigens; 1999 Sep; 54(3):264-72. PubMed ID: 10519363
[TBL] [Abstract][Full Text] [Related]
29. Epistatic Interaction of ERAP1 and HLA-B*51 in Iranian Patients with Behçet's Disease.
Mahmoudi M; Ashraf-Ganjouei A; Javinani A; Shahram F; Meguro A; Mizuki N; Ahmadzadeh N; Jafarinejad-Farsangi S; Mostafaei S; Kavosi H; Faezi ST; Akhlaghi M; Davatchi F
Sci Rep; 2018 Dec; 8(1):17612. PubMed ID: 30514861
[TBL] [Abstract][Full Text] [Related]
30. Targeted resequencing implicates the familial Mediterranean fever gene MEFV and the toll-like receptor 4 gene TLR4 in Behçet disease.
Kirino Y; Zhou Q; Ishigatsubo Y; Mizuki N; Tugal-Tutkun I; Seyahi E; Özyazgan Y; Ugurlu S; Erer B; Abaci N; Ustek D; Meguro A; Ueda A; Takeno M; Inoko H; Ombrello MJ; Satorius CL; Maskeri B; Mullikin JC; Sun HW; Gutierrez-Cruz G; Kim Y; Wilson AF; Kastner DL; Gül A; Remmers EF
Proc Natl Acad Sci U S A; 2013 May; 110(20):8134-9. PubMed ID: 23633568
[TBL] [Abstract][Full Text] [Related]
31. Molecular genetics (HLA) of Behçet's disease.
Mizuki N; Inoko H; Ohno S
Yonsei Med J; 1997 Dec; 38(6):333-49. PubMed ID: 9509902
[TBL] [Abstract][Full Text] [Related]
32. Common MEFV gene mutations in Turkish patients with Behcet's disease.
Tasliyurt T; Yigit S; Rustemoglu A; Gul U; Ates O
Gene; 2013 Nov; 530(1):100-3. PubMed ID: 23973724
[TBL] [Abstract][Full Text] [Related]
33. Genetics of Behçet's disease: lessons learned from genomewide association studies.
Gül A
Curr Opin Rheumatol; 2014 Jan; 26(1):56-63. PubMed ID: 24257369
[TBL] [Abstract][Full Text] [Related]
34. HLA-B*51 allele analysis by the PCR-SBT method and a strong association of HLA-B*5101 with Japanese patients with Behçet's disease.
Mizuki N; Ota M; Katsuyama Y; Yabuki K; Ando H; Shiina T; Nomura E; Onari K; Ohno S; Inoko H
Tissue Antigens; 2001 Sep; 58(3):181-4. PubMed ID: 11703826
[TBL] [Abstract][Full Text] [Related]
35. Association of the MIC-A gene and HLA-B51 with Behçet's disease in Arabs and non-Ashkenazi Jews in Israel.
Cohen R; Metzger S; Nahir M; Chajek-Shaul T
Ann Rheum Dis; 2002 Feb; 61(2):157-60. PubMed ID: 11796403
[TBL] [Abstract][Full Text] [Related]
36. Allelic distribution of HLA-B*5 in HLA-B5-positive Israeli patients with Behçet's disease.
Paul M; Klein T; Krause I; Molad Y; Narinsky R; Weinberger A
Tissue Antigens; 2001 Sep; 58(3):185-6. PubMed ID: 11703827
[TBL] [Abstract][Full Text] [Related]
37. The Relationship between NALP3 and Autoinflammatory Syndromes.
Campbell L; Raheem I; Malemud CJ; Askari AD
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27187378
[TBL] [Abstract][Full Text] [Related]
38. The novel -G646A polymorphism of the TNFalpha promoter is associated with the HLA-B51 allele in Korean patients with Behçet's disease.
Chang HK; Jang WC; Park SB; Nam YH; Lee SS; Park YW; Kim SK
Scand J Rheumatol; 2007; 36(3):216-21. PubMed ID: 17657677
[TBL] [Abstract][Full Text] [Related]
39. Molecular genetic analysis for periodic fever syndromes: a supplemental role for the diagnosis of adult-onset Still's disease.
Li H; Abramova I; Chesoni S; Yao Q
Clin Rheumatol; 2018 Aug; 37(8):2021-2026. PubMed ID: 29909561
[TBL] [Abstract][Full Text] [Related]
40. Tumour necrosis factor-alpha gene promoter region -308 and -376 G-->A polymorphisms in Behçet's disease.
Duymaz-Tozkir J; Gül A; Uyar FA; Ozbek U; Saruhan-Direskeneli G
Clin Exp Rheumatol; 2003; 21(4 Suppl 30):S15-8. PubMed ID: 14727453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
